Financials
Financial year 2025
Worth noting
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ -1,803
▲ 34% vs 2024
Profit
Caution€ -3,205
▲ 7% vs 2024
Debts
High€ 1.8 million
▼ 2% vs 2024
2PHARMA HOLDING from Gent, company number BE0644751377, closed financial year 2025 with a result of € -3,205 after tax. For that financial year 2PHARMA HOLDING recorded a gross margin of € -1,803 and equity of € 34,480. Compared with financial year 2024, the result moved from € -3,465 to € -3,205. The company made a loss. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 30, 2026.
What happened at 2PHARMA HOLDING?
What happened at 2PHARMA HOLDING in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Aquitania BV stepped down as director. NBB
- MD Consult BV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 3,205. Source: NBB ↗
- Aquitania BV became a director. NBB
- MD Consult BV became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2,427 loss in 2021 to € 3,205 loss in 2025.
A new publication or filing at 2PHARMA HOLDING? We notify you, reason included.
Follow 2PHARMA HOLDINGNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Directors
According to the 2025 annual accounts
Director · represented by Anja Imschoot
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, b+pharma Belgium +6 more
since 2026 · until 2032
Managing director · represented by Mario Debel
Also active at: Ceres Pharmaceuticals, VESALE PHARMACEUTICA, MD Pharma +5 more
since 2026 · until 2032
Establishments
Establishment units
Physical locations of this company
Kortrijksesteenweg 1091 box B
9051 Gent
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 20 companies are registered at this address.
Ceres Pharmaceuticals same network
€ 14.6 million revenue · 2025
What's Cooking Group
KOUTERLOS
€ 55,337 gross margin · 2024
b+pharma Belgium same network
€ 287,023 gross margin · 2025
DGPharma same network
€ 94,120 gross margin · 2024
+15 more
Website
Technologies
Hosting & Email
Email provider
Microsoft 365
Hosting
COMBELL-AS, BE
Website info
Features
Security
Details
- Company number
- 0644.751.377
- VAT number
- BE 0644.751.377
- Registered office
- Kortrijksesteenweg 1091 bus B, 9051 Gent
- Names & denominations
- 2PHARMA HOLDING
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 December 2015
- Peppol
- Active · Active since 1 Aug 2025
- Contact
- ceres-pharma.com